Brind.

Cocrystal Pharma presented Phase 1 clinical trial results at a Department of Defense medical conference.

1 report, 1 independent Updated Aug 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Cocrystal Pharma presented Phase 1 clinical trial results at a Department of Defense medical conference.

Who's involved

What this event is mainly about
Cocrystal Pharma

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireCocrystal Pharma Presents Phase 1 Results for Pan-Viral Inhibitor CDI-988 at Department of Defense Medical Conference All CDI-988 doses, ranging from 100 mg to 1200 mg, in the Phase 1 study were well